Your new experience awaits. Try the new design now and help us make it even better

SYSTEMATIC REVIEW article

Front. Pediatr.

Sec. Neonatology

This article is part of the Research TopicAdvances in Immunological Diagnostics for Infectious Diseases and Autoimmune Disorders: Novel Biomarkers, Serology, and Technological DevelopmentsView all 4 articles

Identifying thresholds of C-reactive protein, procalcitonin and interleukin-6 among children ≤ 36 months old with fever without source at risk of serious bacterial infections: a systematic review and meta-analysis

Provisionally accepted
Natalia  SutimanNatalia Sutiman1Jiaying  LinJiaying Lin2Rehena  SultanaRehena Sultana3Sarah  Hui Wen YaoSarah Hui Wen Yao2Sharon  Si Min GohSharon Si Min Goh2Suzanne-Kae  RocknathanSuzanne-Kae Rocknathan4Sashikumar  GanapathySashikumar Ganapathy1Shu-Ling  ChongShu-Ling Chong1*
  • 1Department of Emergency Medicine, KK Women's and Children's Hospital, Singapore, Singapore
  • 2Department of Paediatric Medicine, KK Women's and Children's Hospital, Singapore, Singapore
  • 3Centre of Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore
  • 4Duke-NUS Medical School, Duke-NUS Medical School, Singapore, Singapore

The final, formatted version of the article will be published soon.

ABSTRACT (292 words) INTRODUCTION: Management of children ≤36 months presenting with fever without source remains a challenge because the underlying aetiologies may range from self-limiting viral infections to serious bacterial infections (SBIs) including bacteraemia, urinary tract infection (UTI), pneumonia, bacterial meningitis, osteomyelitis or septic arthritis. This systematic review was conducted to determine the thresholds at which C-reactive protein (CRP), procalcitonin (PCT) and interleukin-6 (IL-6) can predict SBIs in this population. METHODS: We systematically searched electronic databases including MEDLINE, Cochrane, CINAHL and Web of Science for studies evaluating the diagnostic accuracies of CRP, PCT and IL-6 in detecting SBIs in children ≤36 months presenting with fever without source, from November 2013 to November 2023. Area under summary receiver operating curve (SROC) was calculated by the Rutter and Gatsonis method. I2 was used to quantify study heterogeneity. All tests were two-sided and p-value <0.05 was statistically significant. This review is registered with PROSPERO, CRD42023439093. RESULTS: Datasets from 37 studies were included. CRP cut-off of 10-20 mg/L had the highest pooled sensitivity of 0.75 (95% CI: 0.54-0.89) while CRP cut-off of >40 mg/L had the highest pooled specificity 0.92 (95% CI: 0.87-0.95). PCT cut-off of <0.5 ng/ml had the highest pooled sensitivity of 0.7812 (95% CI: 0.59-0.90) but the lowest pooled specificity of 0.69 (95% CI: 0.54-0.81). Based on ROC analysis, CRP cut-off between 10-20 mg/L and PCT cut-off of <0.5 ng/ml showed the best diagnostic performance with pooled AUC of 0.84 (95% CI: 0.79-0.90) and 0.816 (95% CI: 0.727-0.928), respectively. Only 1 study for IL-6 reported that threshold of 20 pg/dL had sensitivity and specificity of 79.1% and 91.6% respectively. CONCLUSION: PCT cut-off of 0.5 ng/ml and CRP cut-off of 10-20 mg/L have the best performance in identifying SBIs in children ≤36 months with fever without source.

Keywords: bacterial, biomarker, Children, Infection, threshold

Received: 09 Sep 2025; Accepted: 02 Jan 2026.

Copyright: © 2026 Sutiman, Lin, Sultana, Yao, Goh, Rocknathan, Ganapathy and Chong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Shu-Ling Chong

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.